Clinical manifestations and survival among adults with (SLE) according to age at diagnosis

Lupus

Volumn 23, Issue 8, 2014, Pages 778-784

  Merola, J F ^a   Bermas, B ^a   Lu, B ^a   Karlson, E W ^a   Massarotti, E ^a   Schur, P H ^a   Costenbader, K H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Age; Male; Mortality; Outcomes; SLE (systemic lupus erythematosus); Survival

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; LEFLUNOMIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; ARTICLE; BLACK PERSON; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; GROUPS BY AGE; HUMAN; INFORMATION PROCESSING; KAPLAN MEIER METHOD; LABORATORY TEST; LOG RANK TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEROLOGY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; AGE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84897936976     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314526291     Document Type: Article

References (25)

1. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 2152-2158.
2. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 1997; 24: 1061-1065.
3. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259-1264.
4. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265-1270.
5. Amador-Patarroyo MJ, Rodriguez-Rodriguez A, Montoya-Ortiz G. How does age at onset influence the outcome of autoimmune diseases? Autoimmune Dis 2012; 2012: 251730.
6. Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314-322.
7. Hersh AO, von Scheven E, Yazdany J, et al. Differences in longterm disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 2009; 61: 13-20.
8. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-124.
9. Alonso MD, Martinez-Vazquez F, de Teran TD, et al. Late-onset systemic lupus erythematosus in Northwestern Spain: Differences with early-onset systemic lupus erythematosus and literature review. Lupus 2012; 21: 1135-1148.
10. Lin H, Wei JC, Tan CY, et al. Survival analysis of late-onset systemic lupus erythematosus: A cohort study in China. Clin Rheumatol 2012; 31: 1683-1689.
11. Tomic-Lucic A, Petrovic R, Radak-Perovic M, et al. Late-onset systemic lupus erythematosus: Clinical features, course, and prognosis. Clin Rheumatol 2013; 32: 1053-1058.
12. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
13. Alarcón GS, McGwin Jr G, Bastian HM, et al. SLE in three ethnic groups XIII. The 'weighted' criteria as predictors of damage. Lupus 2002; 11: 329-331.
14. Alarcón GS, McGwin Jr G, Petri M, Reveille JD, Ramsey- Goldman R, Kimberly RP. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
15. Bastian HM, Roseman JM, McGwin Jr G, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-160.
16. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849-853.
17. Petri M, Purvey S, Fang H, Magder LS. Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort. Arthritis Rheum 2012; 64: 4021-4028.
18. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol 2012; 39: 759-769.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
20. Miller RG. Simultaneous statistical inference. New York: Springer Verlag, 1981.
21. Renau AI, Isenberg DA. Male versus female lupus: A comparison of ethnicity, clinical features, serology and outcome over a 30 year period. Lupus 2012; 21: 1041-1048.
22. Pons-Estel GJ, Alarcón GS, McGwin Jr G, et al. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum 2009; 61: 830-839.
23. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-225.
24. Alarcón GS, McGwin Jr G, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001; 45: 191-202.
25. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmun Rev 2004; 3: 423-453.